Clinical Trial Update: Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients Clinics [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating QRX-3 in outpatients with chronic kidney disease (stages 3–5), including diabetic kidney disease and hypertensive kidney dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Kidney Disease
• Hypertensive Kidney Disease

Drugs mentioned

• QRX-3

Snippet

Sponsor: Ebima Clifford Okundaye | Conditions: Chronic Kidney Disease Stages 3-5, Diabetic Kidney Disease | Phase 2 | Status: COMPLETED